Editorial Article
Europe Is Shrinking Inside a Growing Chemicals Market
A growth number and a closure number that are the same fact
Our olefins forecast has the market moving from USD 315.8 billion in 2025 to USD 498.6 billion in 2033, a 5.9% CAGR. Ethylene is the largest segment, propylene the fastest-growing, packaging the leading end-use, Asia-Pacific the dominant region and the Middle East the fastest-growing.
In the same window, European chemical producers have announced the closure of roughly 37 million tonnes of capacity — close to 9% of the region’s total production capacity, and a sixfold increase on the level announced in 2022. Upstream petrochemicals accounts for nearly half of those announcements, and the petrochemical share of capacity scheduled to close is about 14%. In 2025 the announced closures doubled again on the previous year.
Those two facts are usually presented as a global growth story and a European problem. They are the same fact. The global chemicals market is growing, and Europe’s share of it is being deliberately removed. The relocation is not a symptom of the growth; it is the mechanism.
The figures on the European side come from a study commissioned by Cefic, the European Chemical Industry Council, and carried out by Roland Berger. Cefic’s own estimate of the employment consequence is 20,000 direct jobs and 89,000 indirect ones.
What “the chemicals market” actually measures
A chemicals forecast is a value figure: tonnes multiplied by price, converted to dollars. That makes it unusually sensitive to two things that are not demand.
The first is the price of the marginal tonne. In olefins, the marginal producer sets the clearing price, and the marginal producer is whoever has the cheapest feedstock and the newest cracker — ethane in the Gulf and in the US Gulf Coast, and integrated coal-to-olefins in China. When that producer’s cash cost sits below a European producer’s variable cost, the European plant does not lose a negotiation. It loses the ability to run at all, because running produces cash losses faster than shutting does.
The second is currency and unit convention. A dollar figure converts local revenue at an exchange rate, so a European producer with flat volumes in euros can appear to be shrinking in the global series, and a weak dollar can make an entire region look like it is growing. Neither has anything to do with molecules.
Both effects point the same way in this cycle. The growth in the global figure is being delivered by jurisdictions that are adding capacity; the value in the European part of it is being destroyed by jurisdictions that can produce the same molecule more cheaply. A 5.9% CAGR is therefore not a tide that lifts every producer in the market it describes. It is an average of one region building and another region exiting.
The investment asymmetry is the part that matters
Closures alone would be a cyclical story: capacity comes out, prices recover, capacity comes back. What makes this structural is the other half of the balance.
Over 2022 to 2025, new investment announcements in European chemicals totalled around 7 million tonnes — roughly 2% of regional capacity against 9% being removed. In 2025 specifically, new capacity announcements amounted to 0.3 million tonnes. The net capacity balance across the period is a loss of more than 30 million tonnes a year.
A sixfold rise in closures against a near-absence of new announcements is not a downcycle. It is a decision, taken plant by plant, that the next tonne of European chemical capacity is not worth building. Once that decision is made the asset base does not come back when margins recover, because the engineering contractors have gone, the permits have lapsed and the apprentices have retired. The industry that emerges from the other side of this is smaller at the upstream end permanently, whatever the price of naphtha does.
The specialties are not the safe end of the boat
The comfortable version of this story is that Europe keeps the specialties and cedes the commodities, because specialties are specification-driven and sold on service. There is something in that — a formulated product carries technical support, registration and a warranty that a commodity tonne does not.
But the specialty formulator buys intermediates. A coatings maker buys resins and solvents; a crop-protection formulator buys intermediates; an adhesive maker buys monomers. If the intermediates come from plants that no longer exist in the region, the specialty producer’s input cost is now an import price plus freight plus the carbon border adjustment mechanism, which begins charging for embedded emissions in fertilisers, iron and steel, aluminium, cement, electricity and hydrogen.
That is the transmission channel, and it is why the closure programme shows up not only in commodity margins but in the cost base of companies that never announced a closure. The specialty end keeps its customers and loses its cost position — which is a slower, less visible way of being squeezed out of the same market.
What would break the thesis
- A sustained fall in European energy and feedstock costs relative to the US and the Gulf. Nothing in the current investment data suggests it, but it is the only variable that would restore the arithmetic at the upstream end.
- Chinese capacity rationalisation. A genuine retirement programme in China would tighten the marginal price and make European plants viable as swing capacity again — the opposite of the current direction.
- Defence, electrification and grid spending creating a new specialty pool. Demand for fluoropolymers, battery materials and electronic chemicals is real, but it is small against the commodity base being removed, and it is being built where the incentives are.
The investor’s version
The mistake this market invites is buying European chemical assets because they trade below replacement cost. Replacement cost is only a floor if someone would replace them. With new announcements at 0.3 million tonnes in a year, the market is telling you the answer: the asset is cheap because the replacement will not happen, and a plant that cannot earn its variable cost is not worth its scrap value plus the remediation liability attached to it.
The growth in the global number is real. It is accruing to the licensors, the catalyst suppliers, the engineering contractors who build in the Gulf and in Asia, and the shipping that moves the molecule — not to the plants in the jurisdiction that is net removing capacity. A 5.9% market with 9% of one region’s capacity coming out is not a contradiction. It is a relocation, and relocations are only growth if you are standing where the capacity lands.
Frequently Asked Questions
How large is the global olefins market and how fast is it growing?
Our forecast puts the global olefins market — the commodity backbone of the chemicals industry — at USD 315.8 billion in 2025, rising to USD 498.6 billion by 2033, a 5.9% CAGR. Ethylene is the largest segment, propylene the fastest-growing, and packaging the leading end-use segment.
How much European chemical capacity is closing?
A study commissioned by Cefic and carried out by Roland Berger puts announced European chemical capacity closures between 2022 and 2025 at roughly 37 million tonnes — close to 9% of the region's production capacity, with upstream petrochemicals more heavily affected at about 14%. Announced closures doubled in 2025 versus 2024.
Why can the chemicals market grow while Europe shrinks?
Because the global figure is a value average of one region adding capacity and another removing it. The marginal tonne is produced where feedstock and energy are cheapest, so European plants become price-takers whose variable cost exceeds the marginal producer's cash cost. Growth in the aggregate and contraction in Europe are the same relocation seen from two ends.
Will the closed European capacity come back?
Roughly 7 million tonnes of new investment was announced between 2022 and 2025 against 37 million tonnes of closures, and in 2025 alone new capacity announcements were only 0.3 million tonnes. That asymmetry means the removed capacity is unlikely to return even if margins recover, because the supply chain, permits and workforce that would rebuild it are gone.